Skip to main content

Advertisement

Log in

Overactive bladder: drug therapy versus nerve stimulation

  • Viewpoint
  • Published:

From Nature Clinical Practice Urology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abrams P et al. (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21: 167–178

    Article  Google Scholar 

  2. Chapple CR et al. (2002) Muscarinic receptor subtypes and management of the overactive bladder. Urology 60 (Suppl 1): 82–89

    Article  Google Scholar 

  3. Andersson KE and Yoshida M (2003) Antimuscarinics and the overactive detrusor—which is the main mechanism of action? Eur Urol 43: 1–5

    Article  CAS  Google Scholar 

  4. Igawa Y (2000) Discussion: functional role of M(1), M(2), and M(3) muscarinic receptors in overactive bladder. Urology 55 (Suppl A): 47–49

    Article  CAS  Google Scholar 

  5. Choppin A and Eglen RM (2001) Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle. Br J Pharmacol 132: 835–842

    Article  CAS  Google Scholar 

  6. Lai H et al. (2002) Selecting a medical therapy for overactive bladder. Reviews in Urology 4 (Suppl 4): S28–S37

    PubMed  PubMed Central  Google Scholar 

  7. Yarker YE et al. (1995) Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging 6: 243–262

    Article  CAS  Google Scholar 

  8. Abrams P et al. (1998) Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 81: 801–810

    Article  CAS  Google Scholar 

  9. Tanagho EA et al. (1989) Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol 142 (Pt 1): 340–345

    Article  CAS  Google Scholar 

  10. Hassouna MM et al. (2000) Sacral neuromodulation in the treatment of urgency–frequency symptoms: a multicenter study on efficacy and safety. J Urol 163: 1849–1854

    Article  CAS  Google Scholar 

  11. Chartier-Kastler EJ et al. (2000) Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol 164: 1476–1480

    Article  CAS  Google Scholar 

  12. Aboseif S et al. (2002) Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction. Urology 60: 52–56

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sherif R Aboseif.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Glossary

DETRUSOR OVERACTIVITY (DO)

Involuntary detrusor muscle contractions during the filling phase; may be spontaneous or provoked

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pathak, A., Aboseif, S. Overactive bladder: drug therapy versus nerve stimulation. Nat Rev Urol 2, 310–311 (2005). https://doi.org/10.1038/ncpuro0227

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0227

  • Springer Nature Limited

This article is cited by

Navigation